Deborah Schrag, MD
Articles
September 15th 2015
The Utility of Cost Discussions Between Patients With Cancer and Oncologists
S. Yousuf Zafar, MD, MHS Fumiko Chino, MD Peter A. Ubel, MD Christel Rushing, MS Gregory Samsa, PhD Ivy Altomare, MD Jonathan Nicolla, MBA Deborah Schrag, MD James A. Tulsky, MD Amy P. Abernethy, MD, PhD Jeffery M. Peppercorn, MD, MPH
Many patients with cancer desire cost discussions with doctors, but those discussions are rare. Nevertheless, cost discussions may lower patient costs-usually without altering treatment.
Latest Updated Articles
Published: April 1st 2024 | Updated: November 5th 2024
What We're Reading: Concierge Nonprofit Hospitals; Kaiser Permanente Elderly Care Program; Health Care Not Among Top Voter Issues
Published: October 21st 2024 | Updated: October 24th 2024
Lower Diagnostic Error Rates Found Among Hospitalized Patients During Care Transitions
Published: September 26th 2024 | Updated: October 1st 2024
Addressing Natural Disaster Takes Cooperation, Preparation to Ensure Patient Health
Published: May 9th 2024 | Updated: May 21st 2024
FDA Accepts Nivolumab Subcutaneous Injection Application, With Potential to Boost Access to PD-1 Inhibitors
Published: April 1st 2024 | Updated: November 5th 2024
What We're Reading: Concierge Nonprofit Hospitals; Kaiser Permanente Elderly Care Program; Health Care Not Among Top Voter Issues
Published: October 20th 2024 | Updated: November 8th 2024
FLT3 Inhibitor Gilteritinib May Also Be Effective as ALK Inhibitor in AML
